In a first-of-its-kind analysis, Cornell researchers and partners at the Clinton Health Access Initiative found that pharmaceutical producers could reduce their environmental impact by roughly half by optimizing manufacturing processes and supply chain networks and by switching to renewable energy sources.
As the world population grows and climate change threatens agriculture and global food systems, researchers across Cornell CALS are reimagining agri-food systems for the 21st century.
People who refused to get vaccinated against COVID-19 had low levels of social trust, weak attachments to the rule of law, and were less willing to honor collective commitments to the greater good, according to Cornell research published today.
Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.
Working with physicians at Weill Cornell Medicine and therapists at the Cayuga Medical Center, Cornell Hybrid Body Lab researchers have devised a knitted wearable technology that can ease discomfort caused by hand edema.
The Sloan Program in Health Administration in the Cornell Jeb E. Brooks School of Public Policy has once again been ranked among the best in the nation. The new U.S. News rankings have the program rising to the No. 8 spot.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
The Cornell Center for Health Equity has launched its racial allyship training course, providing anyone who wants to learn to be a better ally with essential skills and tools they can use in their personal and professional lives.
